NO307787B1 - Xantinforbindelser med terminalt aminerte alkinolsidekjeder, legemidler inneholdende forbindelsene samt anvendelser av forbindelsene for fremstilling av legemidler - Google Patents

Xantinforbindelser med terminalt aminerte alkinolsidekjeder, legemidler inneholdende forbindelsene samt anvendelser av forbindelsene for fremstilling av legemidler

Info

Publication number
NO307787B1
NO307787B1 NO972581A NO972581A NO307787B1 NO 307787 B1 NO307787 B1 NO 307787B1 NO 972581 A NO972581 A NO 972581A NO 972581 A NO972581 A NO 972581A NO 307787 B1 NO307787 B1 NO 307787B1
Authority
NO
Norway
Prior art keywords
compounds
drugs
alkinol
preparation
side chains
Prior art date
Application number
NO972581A
Other languages
English (en)
Norwegian (no)
Other versions
NO972581D0 (no
NO972581L (no
Inventor
Ulrich Gebert
Elisabeth Defossa
Uwe Heinelt
Karl Rudolphi
John J Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19622734A external-priority patent/DE19622734A1/de
Priority claimed from DE1996136882 external-priority patent/DE19636882A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO972581D0 publication Critical patent/NO972581D0/no
Publication of NO972581L publication Critical patent/NO972581L/no
Publication of NO307787B1 publication Critical patent/NO307787B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO972581A 1996-06-07 1997-06-06 Xantinforbindelser med terminalt aminerte alkinolsidekjeder, legemidler inneholdende forbindelsene samt anvendelser av forbindelsene for fremstilling av legemidler NO307787B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19622734A DE19622734A1 (de) 1996-06-07 1996-06-07 Xanthinverbindungen mit terminal aminierten Alkinol-Seitenketten
DE1996136882 DE19636882A1 (de) 1996-09-11 1996-09-11 Xanthinverbindungen mit terminal aminierten Alkinol-Seitenketten

Publications (3)

Publication Number Publication Date
NO972581D0 NO972581D0 (no) 1997-06-06
NO972581L NO972581L (no) 1997-12-08
NO307787B1 true NO307787B1 (no) 2000-05-29

Family

ID=26026371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972581A NO307787B1 (no) 1996-06-07 1997-06-06 Xantinforbindelser med terminalt aminerte alkinolsidekjeder, legemidler inneholdende forbindelsene samt anvendelser av forbindelsene for fremstilling av legemidler

Country Status (26)

Country Link
US (1) US5965555A (fr)
EP (1) EP0811623B1 (fr)
JP (1) JP4263778B2 (fr)
KR (1) KR100531964B1 (fr)
CN (1) CN1064361C (fr)
AR (1) AR013821A1 (fr)
AT (1) ATE200288T1 (fr)
AU (1) AU712717B2 (fr)
BR (1) BR9703500B1 (fr)
CA (1) CA2207258C (fr)
CZ (1) CZ292509B6 (fr)
DE (1) DE59703271D1 (fr)
DK (1) DK0811623T3 (fr)
ES (1) ES2155640T3 (fr)
GR (1) GR3035711T3 (fr)
HU (1) HU224702B1 (fr)
ID (1) ID17468A (fr)
IL (1) IL120998A (fr)
MX (1) MX9704201A (fr)
MY (1) MY117764A (fr)
NO (1) NO307787B1 (fr)
NZ (1) NZ328018A (fr)
PL (1) PL186238B1 (fr)
PT (1) PT811623E (fr)
RU (1) RU2204561C2 (fr)
TW (1) TW384289B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284708A (en) * 1993-12-07 1995-06-14 At & T Corp Method for passivation of multi-quantum well infrared photodetectors (QWIPS) to reduce dark current and to improve dark current uniformity
SI1953162T1 (sl) * 2001-02-24 2012-09-28 Boehringer Ingelheim Pharma Ksantinski derivati, njihova priprava in njihova uporaba kot zdravila
AU2002322562A1 (en) * 2001-07-19 2003-03-03 Medical College Of Georgia Research Institute Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
CA2496249C (fr) * 2002-08-21 2012-01-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-[3-amino-piperidin-1-yl]-xanthines, leur production et leur utilisation comme medicament
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (fr) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Compositions d'inhibiteurs de la DPP IV
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
BRPI0711558A2 (pt) * 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
NZ600126A (en) * 2007-08-17 2013-12-20 Boehringer Ingelheim Int Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
KR101657960B1 (ko) * 2008-08-15 2016-09-20 베링거 인겔하임 인터내셔날 게엠베하 Ｆａｂ-관련 질환의 치료에 사용하기 위한 푸린 유도체
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (fr) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Formes de sel d'un composé organique
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
MX341025B (es) 2010-05-05 2016-08-04 Boehringer Ingelheim Int Gmbh * Terapia de combinacion.
PH12012502524A1 (en) 2010-06-24 2014-02-10 Boehringer Ingelheim Int Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (fr) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Dérivé de quinazoline dimère substitué, sa préparation et son utilisation dans des compositions pharmaceutiques pour le traitement du diabète de type i et ii
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303554A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in sirs and/or sepsis
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (fr) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007197A (en) * 1975-06-10 1977-02-08 The Dow Chemical Company Process for preparing phosphorothioates and phenylphosphonothioates
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0223403B1 (fr) * 1985-10-25 1993-08-04 Beecham Group Plc Dérivé de pipéridine, sa préparation et son utilisation comme médicament
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
RU2075572C1 (ru) * 1994-11-22 1997-03-20 Алексей Егорович Пережилов Способ формирования изоляционной завесы вокруг горных выработок

Also Published As

Publication number Publication date
DK0811623T3 (da) 2001-07-23
BR9703500A (pt) 1998-10-06
JPH1059968A (ja) 1998-03-03
MX9704201A (es) 1998-04-30
TW384289B (en) 2000-03-11
CN1169994A (zh) 1998-01-14
CA2207258A1 (fr) 1997-12-07
RU2204561C2 (ru) 2003-05-20
MY117764A (en) 2004-08-30
HU224702B1 (en) 2006-01-30
IL120998A (en) 2000-07-16
ATE200288T1 (de) 2001-04-15
HUP9701018A2 (hu) 1998-12-28
DE59703271D1 (de) 2001-05-10
BR9703500B1 (pt) 2010-05-18
CA2207258C (fr) 2006-08-08
NO972581D0 (no) 1997-06-06
NZ328018A (en) 1998-09-24
KR19980024046A (ko) 1998-07-06
EP0811623B1 (fr) 2001-04-04
PL320414A1 (en) 1997-12-08
CZ174297A3 (en) 1997-12-17
NO972581L (no) 1997-12-08
US5965555A (en) 1999-10-12
GR3035711T3 (en) 2001-07-31
JP4263778B2 (ja) 2009-05-13
AR013821A1 (es) 2001-01-31
PL186238B1 (pl) 2003-12-31
HUP9701018A3 (en) 2000-01-28
EP0811623A1 (fr) 1997-12-10
KR100531964B1 (ko) 2006-03-17
CN1064361C (zh) 2001-04-11
PT811623E (pt) 2001-09-28
AU2469997A (en) 1997-12-11
IL120998A0 (en) 1997-11-20
CZ292509B6 (cs) 2003-10-15
HU9701018D0 (en) 1997-07-28
ES2155640T3 (es) 2001-05-16
AU712717B2 (en) 1999-11-11
ID17468A (id) 1998-01-08

Similar Documents

Publication Publication Date Title
NO304488B1 (no) 5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen
NO304468B1 (no) 6-leddede nitrogenholdige heteroaryl-oksazolidinoner, anvendelse av disse samt legemiddel inneholdende forbindelsen
FI964249L (fi) Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti
DK0811623T3 (da) Xanthinforbindelser med terminalt aminerede alkynolsidekæder
BR9710808A (pt) Derivados biciclicos 6,6 ou 6,7 contendo pirito ou pirimido substitu¡dos
NO904446D0 (no) Additivkonsentrat for polymere materialer, samt fremstilling av additivkonsentratet.
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
IL135589A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing the same
DK654589A (da) Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
NO923466D0 (no) Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser
HUP9904335A3 (en) Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
HUP0102453A3 (en) Adenosine derivatives, their use and pharmaceutical compositions containing the compounds
AU3460297A (en) Taxane derivatives and drugs containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
ZA974984B (en) New substituted thiazolidine-2,4-dione derivatives, processes for the obtaining thereof, and pharmaceutical compositions containing them.
ZA941993B (en) Amidine derivatives containing heterocyclic groups the preparation and use thereof
HUP0000719A3 (en) Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
BR9505126A (pt) Fechamento de segurança para garrafas e semelhantes
NO308705B1 (no) Partikkelformet material omfattende titandioksyd, fremgangsmÕte for fremstilling derav samt dispersjon omfattende materialet
ZA986273B (en) Purine derivatives and the use for medicine thereof.
NO911252L (no) Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene.
NO305795B1 (no) Substituerte benzensulfonylurinstoffer og -tiourinstoffer, og anvendelse i farmas°ytiske preparater pÕ basis av disse forbindelsene samt legemidler inneholdende forbindelsene
IL129574A0 (en) Benzenesulfonamide derivatives and drugs containing the same
DE69019097D1 (de) Azlactonfunktionen aufweisende Siliciumverbindungen und deren Derivate.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees